Literatur
- 1
Koch R.
Die Aetiologie der Tuberculose.
Berliner Klin Wschr.
1882;
15
221-230
- 2
Ehrlich P.
Robert Koch (1848 - 1910).
Frankfurter Allg Zeitung, Pneumologie.
2007;
61
XX
- 3 Rössle R. Tuberkulose. In: Behring zum Gedächtnis. Berlin: Bruno Schultz 1942: 137-148
- 4
Mitchison D A.
The diagnosis and therapy of tuberculosis during the past 100 years.
Am J Resp Crit Care Med.
2005;
171
699-706
- 5
Kaufmann S HE, Baumann S, Nasser Edine A.
Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.
Int J Tuberc Lung Dis.
2006;
10
1068-1079
- 6
Davies P DO.
The world-wide increase in tuberculosis: how demographic change, HIV infection and
increasing numbers in poverty are increasing tuberculosis.
Ann Med.
2003;
35
235-243
- 7 Billo N. Tuberkulose in der Dritten Welt. In: Konietzko N, Loddenkemper R (Hrsg).
Tuberkulose. Stuttgart: Thieme 1999: 228-234
- 8 World Health Organization .Global tuberculosis control: surveillance, planning,
financing. WHO Report 2006. Genf: World Health Organization, (WHO/HTM/TB/2006.362)
2006
- 9 World Health Organization .Guidelines for establishing DOTS-Plus pilot projects
for the management of multidrug-resistant tuberculosis (MDR-TB). Genf: World Health
Organization, (WHO/CDS/TB/2000.279) 2000
- 10 Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose .23. Informationsbericht. Berlin:
DZK 1997
- 11 Robert Koch-Institut .Zur Situation bei wichtigen Infektionskrankheiten in Deutschland:
Tuberkulose im Jahr 2005. In: Epidemiologisches Bulletin Nr. 44. Berlin: Robert Koch-Institut
2006: 379-382
- 12
Corbett E L, Marston B, Churchyard G J. et al .
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era
of antiretroviral treatment.
Lancet.
2006;
367
926-937
- 13 Robert Koch-Institut .Welt-AIDS-Tag 2006. Zum Stand der HIV/AIDS-Epidemie in Europa. In:
Epidemiologisches Bulletin Nr. 47. Berlin: Robert Koch-Institut 2006: 411-415
- 14
Zignol M, Hosseini M S, Wright A. et al .
Global incidence of multidrug-resistant tuberculosis.
J Infect Dis.
2006;
194
479-485
- 15 Hauer B, Kunitz F, Sagebiel D. et al .Untersuchungen zur Tuberkulose in Deutschland:
Molekulare Epidemiologie, Resistenzsituation und Behandlung (überarbeiteter Abschlussbericht
zur DZK-Studie). Berlin: DZK 2006
- 16
Gandhi N R, Moll A, Sturm A W. et al .
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected
with tuberculosis and HIV in a rural area of South Africa.
Lancet.
2006;
368
1575-1580
- 17
Centers for Disease Control and Prevention .
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs
- worldwide, 2000 - 2004.
MMWR Weekly.
2006;
55
301-305
- 18
Migliori G B, Loddenkemper R, Blasi F. et al .
125 years after Robert Koch’s discovery of the tubercle bacillus - the new XDR-TB
threat. Is „science” enough to tackle the epidemic?.
Eur Respir J.
2007 (März);
29
im Druck
- 19
Raviglione M C, Uplekar M W.
WHO’s new TB strategy.
Lancet.
2006;
367
952-955
- 20
Anonymous .
Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and
control.
Wkly Epidemiol Rec.
2006;
81
430-432
- 21 Stop TB Partnership and World Health Organization .The Global Plan to Stop TB 2006
- 2015. Genf: World Health Organization 2006
- 22
Koch R.
Epidemiologie der Tuberkulose.
Zeitschr Hygiene und Infektionskrankheiten.
1910;
67
1-18
- 23
Perkins M D, Roscigno G, Zumla A.
Progress towards improved tuberculosis diagnostics for developing countries.
Lancet.
2006;
367
942-943
- 24
Spiegelman M, Gillespie S.
Tuberculosis drug development pipeline: progress and hope.
Lancet.
2006;
367
945-347
- 25
Murray J F.
A century of tuberculosis.
Am J Respir Crit Care Med.
2004;
169
1181-1186
- 26
Achmat Z.
Science and social justice: the lessons of HIV/AIDS activism in the struggle to eradicate
tuberculosis.
Int J Tuberc Lung Dis.
2006;
10
1312-1317
Prof. Dr. Robert Loddenkemper
Generalsekretär des DZKLungenklinik Heckeshorn HELIOS Klinikum Emil von Behring
Walterhöferstr. 11
14165 Berlin
Email: loddheck@zedat.fu-berlin.de
